Cat /

Breed profile · FDA CVM July 2026 extract

Egyptian Mau adverse-event record

Adverse-event filings for Egyptian Mau (Cat) in the FDA Center for Veterinary Medicine openFDA extract. Browse cat breeds, reactions, and outcomes below.

Verify with FDA CVM →
#266 of 510
by report volume (all breeds)
57
FDA CVM reports on file
5.3%
death-coded share of reports
#114 of 275
by death-coded share (≥50 reports)

How the 57 reports break down

By recorded gender -- every report on file for Egyptian Mau, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 7 5.25 3.5 1.75 0 2018 2019 2020 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Egyptian Mau drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Egyptian Mau ranks #266 of 510 by total reports (57) and #114 of 275 by death-coded share (5.3%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#266
This breed, reports of 510
#114
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Egyptian Mau has 57 reports now versus 53 in that prior snapshot: 4 more (7.5%).

Report change
+4
Death-coded reports
+0
Death-coded share
−0.4 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Egyptian Mau changes

Total Reports

57

Below-median volume

Deaths Reported

3

of 57 reports

Death-coded share of reports

5.3%

Above-median death-coded share

Avg Age at Report

7.3 yr

5.1 kg avg weight

Death-Coded Outcome Share

Egyptian Mau death-coded reports 5.3%
Cross-breed median

5.3% of 57 egyptian mau reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Egyptian Mau's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

5% 58th percentile Higher share than 58% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Egyptian Mau 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 5.1 kg (11.2 lbs)

Top Reported Reactions

Application site hair loss 8
Vomiting 5
Lethargy (see also Central nervous system depression in 'Neurological') 4
Lack of efficacy (ectoparasite) - flea 4
Lethargy (see also Central nervous system depression in Neurological) 4

Most Referenced Drugs

Selamectin;Sarolaner 8
Selamectin 6
Frunevetmab 6
Fluralaner Spot-On Solution 5
Cefovecin 5

Outcome Breakdown

Ongoing
26 (49.1%)
Outcome Unknown
15 (28.3%)
Recovered/Normal
8 (15.1%)
Died
3 (5.7%)
Recovered with Sequela
1 (1.9%)

Gender Distribution

Male 33 (57.9%)
Female 22 (38.6%)
Unknown 1 (1.8%)
Mixed 1 (1.8%)

Reports by Year

Year Reports Trend
2010 2
2011 2
2012 1
2014 2
2015 1
2016 2
2017 9
2018 3
2019 6
2020 3
2022 4
2023 7
2024 6
2025 5
2026 4

Egyptian Mau FDA adverse-event insights

Signature read: death-coded share at 5.3% is the standout outcome stamp on Egyptian Mau's FDA row. According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Egyptian Mau sits at #266 of 510 by report volume among all breeds and #34 of 55 among cat breeds, with 57 reports and 3 (5.3%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #114 of 275. Mean age at report: 7.3 years, average weight 5.1 kg (11.2 lbs).

Top reported signs: Application site hair loss (8), Vomiting (5), Lethargy (see also Central nervous system depression in 'Neurological') (4). Most-referenced drug: Selamectin;Sarolaner (8 reports), followed by Selamectin (6) and Frunevetmab (6).

Outcome coding on 53 status-recorded reports is dominated by Ongoing (49.1%). Annual submissions ranged 1-2,026 across 15 years on file.

Cat Breeds With a Similar Report Volume

Showing 6 of 54 cat breeds in our dataset, ranked by closest report volume.

European
54 reports · 13.0% death-coded
Scottish Fold Shorthair
60 reports · 8.3% death-coded
Oriental
64 reports · 3.1% death-coded
Birman (Sacred Birman)
65 reports · 3.1% death-coded
American Bobtail
44 reports · 4.5% death-coded
Balinese
42 reports · 9.5% death-coded

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Egyptian Mau, both outside the Cat family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (5.3% death-coded here).

Griffon - Brussels 5.3% · Dog Terrier - Silky 5.2% · Dog Pinscher - Miniature 5.2% · Dog Pug 5.2% · Dog

What to do with this cat

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Egyptian Mau? ▼
There are 57 adverse event reports involving Egyptian Mau in the FDA database, of which 3 were death-coded (5.3% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Egyptian Mau ranks #266 of 510 by report volume among all breeds PlainBreed indexes (#34 of 55 among cat breeds).
Where does Egyptian Mau sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Egyptian Mau is #266 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Cat, it is #34 of 55. Among breeds with at least 50 reports, its death-coded share ranks #114 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Egyptian Mau? ▼
The most commonly reported adverse reactions for Egyptian Mau are Application site hair loss (8 reports), Vomiting (5 reports), Lethargy (see also Central nervous system depression in 'Neurological') (4 reports), Lack of efficacy (ectoparasite) - flea (4 reports), Lethargy (see also Central nervous system depression in Neurological) (4 reports).
What drugs are most frequently associated with Egyptian Mau adverse events? ▼
The drugs most frequently referenced in Egyptian Mau adverse event reports are Selamectin;Sarolaner (8 reports), Selamectin (6 reports), Frunevetmab (6 reports), Fluralaner Spot-On Solution (5 reports), Cefovecin (5 reports).
What is the average age of Egyptian Mau in adverse event reports? ▼
The average age of Egyptian Mau at the time of adverse event reports is 7.3 years, with an average weight of 5.1 kg (11.2 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Egyptian Mau (Cat), extract as of July 2026 extract. 57 reports · 3 death-coded (5.3% of reports, not a mortality rate) · #266 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →